DNA purine N7 positions (N7-G/A)

The N7 position of purine bases, particularly guanine, is the most nucleophilic site in the DNA double helix and serves as a primary molecular target for many classic chemotherapeutic agents. Platinum-based drugs, such as cisplatin, and various alkylating agents, such as nitrogen mustards, interact with this site to form stable covalent bonds or coordination complexes. These modifications lead to the formation of DNA adducts and cross-links that distort the DNA structure and prevent the progression of DNA and RNA polymerases. Consequently, the cell's ability to replicate its genome and express essential genes is compromised, leading to cell cycle arrest and the induction of programmed cell death (apoptosis). While these agents are highly effective in treating various malignancies by targeting rapidly dividing cells, their lack of genomic specificity results in significant side effects, including bone marrow suppression and damage to the kidneys and hearing. Understanding the repair mechanisms that target N7-modified purines, such as nucleotide excision repair, is critical for predicting drug resistance and optimizing therapeutic outcomes [Source: PubMed, PMID: 17014108; NIH, PubChem].

Other names

N7-guanineN7-adenineDNA N7-alkyl acceptor sitePurine N7 positionGuanine N7 position

Drugs target the N7 position of purines (primarily guanine) to form covalent DNA adducts or coordination complexes, resulting in intrastrand and interstrand cross-links that physically obstruct DNA replication and transcription, ultimately triggering apoptosis [Source: PubMed, PMID: 17014108; StatPearls, NBK544284].